laquinimod (Active Biotech)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Namelaquinimod (Active Biotech)
Drug Alias Namelaquinimod
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAryl hydrocarbon receptor agonists
TargetsAryl hydrocarbon receptor
Therapy Area/IndicationsUveitisWet age-related macular degeneration
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwedenAustria
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesActive Biotech Ab
China Registration ClassN/A

Develop Information

Active CompaniesActive Biotech Ab
Inactive CompaniesN/A
Active IndicationsUveitisWet age-related macular degeneration
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A